Clinical Trials
151 trialsIn This Study, a Retrospective Analysis Was Conducted to Explore the Risk Factors for Patients Undergoing Pancreaticoduodenal Surgery (PD) to Achieve TO, and a Nomogram Prediction Model Was Further Established to Promote the Standardization and Standardization of PD Surgical Quality Evaluation.
Changzhou No.2 People's Hospital
EDEN
GCS Ramsay Santé pour l'Enseignement et la Recherche
QPCS
McGill University Health Centre/Research Institute of the McGill University Health Centre
Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis
Beijing Friendship Hospital
BESTDRAIN
Radboud University Medical Center
ARGONAUT: Stool and Blood Sample Bank for Cancer Patients
Persephone Biosciences
ONFM-SBRT
Peking University Third Hospital
Pancreatic Cancer & Surgical Resection
Methodist Health System
AiPPEAR
University Medical Center Goettingen
Lipoprotein a is an Independent Risk Factor for Overall Survival in Patients With Pancreatic Cancer: a Propensity Score Matching Analysis
The Affiliated Hospital of Qingdao University
VANISSh
IRCCS San Raffaele
CAOS
IRCCS San Raffaele
Diagnosis of Pancreatic Cancer by Purine Metabolite (Hypoxanthine, Xanthine) in Urine
Seoul National University Hospital
TIM-DYS
Hospices Civils de Lyon
Pancreatic Cancer Molecular Sub-classification Using Endoscopic Ultrasound Tissue Core Biopsy Samples
Catholic University of the Sacred Heart
Clinical Comparative Study of Systematic Therapy Combined With MWA and Systematic Therapy for Pancreatic Cancer
Chinese PLA General Hospital
PRO-PANC1
IRCCS San Raffaele
The Survival Outcome of Adjuvant Chemotherapy for Stage I Pancreatic Cancer
Tianjin Medical University Cancer Institute and Hospital
PRO-TECT
Kaiser Permanente
Surgical Results of Resection of Locally Advanced Pancreatic Cancer
Assiut University
PaTR-VTE
University of Thessaly
Dissecting the Pattern of Nodal Spread in Post-neoadjuvant Pancreatoduodenectomy
Universita di Verona
Quality of Life of Pancreatic Cancer Patients:Psychometric Validation of Chinese Version in Taiwan
Taipei Veterans General Hospital, Taiwan
Cross-sectional Survey on Palliative Therapy for Pancreatic Cancer Patient
Peking Union Medical College Hospital
PC-TOX
University College, London
A Preoperative Model to Predict the Lymphovascular Invasion in Pancreatic Ductal Adenocarcinoma
Tianjin Medical University Cancer Institute and Hospital
Application of "Heidelberg Triangle" Dissection in Pancreatoduodenectomy and Distal Pancreatectomy
Fudan University
Investigating the Diagnostic Potential of Tear Proteins in Cancer - A Pilot Study
Namida Lab
Microbial Diversity of Pancreatic Diseases
Ruijin Hospital
Application of ctDNA in Evaluation of Neoadjuvant Chemotherapy Efficacy and Exploration of Chemoresistance Mechanisms in Pancreatic Cancer
Shanghai Zhongshan Hospital
PANEXPEL
University Hospital, Montpellier
VERVE
Royal Marsden NHS Foundation Trust
NODES
University of Pecs
CADENCE
MiRXES Pte Ltd
ReMeTTI
Fondation Hôpital Saint-Joseph
U01-Biomarkers for Noninvasive and Early Detection of Pancreatic Cancer
Hoag Memorial Hospital Presbyterian
Radiographic Response to Chemotherapy in Unresected Localized Pancreatic Cancer
Peking Union Medical College Hospital
FOCUS
Academisch Ziekenhuis Maastricht
Pancreatic Cancer Recurrence in the Netherlands
UMC Utrecht
Porto-Venous Radiomics in Pancreatic Cancer
Royal Marsden NHS Foundation Trust
Using Digestive Microbial Information to Enhance the Early Detection of Pancreatic Cancer
Peking Union Medical College Hospital
PANDEMIC
Azienda Ospedaliera Universitaria Integrata Verona
A Prospective Study of UCAD for Diagnosing Benign or Malignant Biliary Obstruction and Follow-up
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Clinical Study of Pan-cancer DNA Methylation Test in Plasma
Wuhan Ammunition Life-tech Co., Ltd
Radiomics in Pancreatic Cancer
Ruijin Hospital
Association Between Cell-free Nucleic Acid in Blood, Urine and Microbiome in Stool With Pancreatobiliary Cancer
Seoul National University Hospital
DNA Mutation Detection in Circulating Tumor DNA and Tissue by mmADPS for Pancreatic Cancer
Seoul National University Hospital
Early Detection of Pancreatic Cancer
Tianjin Medical University Cancer Institute and Hospital
Change of Treatment Landscape and Survival in Metastatic Pancreatic Cancer After Nal-IRI in Republic of Korea
Yonsei University
Intestinal Microbiota Impact for Prognosis and Treatment Outcomes in Early Luminal Breast Cancer and Pancreatic Cancer Patients
Moscow Clinical Scientific Center